arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BioCorRx Inc.

BICX

— Price unavailable

17 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

BioCorRx Inc. shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap —

Dividend Yield —

Revenue Growth 10301.1% ↗

Op. Margin None

ROIC 43.0% →

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$797.24K

↑ +10301.1% —

Net Income Profit after all expenses

$-3.44M

↑ +32.6% —

Operating Margin Operating profit as % of sales

-439.8%

↓ -41.5% —

FCF / Share Free cash flow per share

$0.00

↑ +109.4% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Financial Health ↑

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	10301.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+205922%)	-91.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1928%)	-58.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1266%)	343.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6760%)	-60.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1313%)	-49.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1079%)	-36.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-824%)	-42.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-954%)	-6.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-227%)	-24.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-582%)	-21.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-521%)	63.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1175%)	-17.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-453%)	12.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+150%)	434.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8589%)	—	—
Net Income Growth YoY (%)	32.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-35.4% Weak ↓ Weak Declining Year-over-year change in net income	13.9% Fair ↑ Fair Improving Year-over-year change in net income	16.0% Good ↑ Good Improving Year-over-year change in net income	-48.6% Weak ↓ Weak Declining Year-over-year change in net income	42.0% Excellent ↑ Excellent Improving Year-over-year change in net income	8.1% Fair ↑ Fair Improving Year-over-year change in net income	77.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-403.1% Weak ↓ Weak Declining Year-over-year change in net income	-26.5% Weak ↑ Weak Improving Year-over-year change in net income	-49.2% Weak ↑ Weak Improving Year-over-year change in net income	18.5% Good ↑ Good Improving Year-over-year change in net income	-333.3% Weak ↓ Weak Declining Year-over-year change in net income	-116.6% Weak Weak Year-over-year change in net income	-164.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	N/M	-244.5% Weak Weak Year-over-year change in free cash flow	17.8% Good Good Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	55.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-45.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-10.1% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-3.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-49.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-42.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-30.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-25.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-17.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-0.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	2.1% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	14.9% Good Good Compound annual revenue growth over 3 years	70.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	45.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-49.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-25.0% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-20.1% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-41.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-33.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-27.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-12.0% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-5.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-1.9% Weak Weak Compound annual revenue growth over 5 years	45.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	-439.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3765%)	-310.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2691%)	—	-260.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2272%)	—	—	—	—	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-431.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-5494%)	—	—	—	—	—	—	—	—	—	—	-267.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3439%)	—	-102.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1375%)	-53.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-762%)	-107.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1438%)	—
FCF Margin (%) (%)	-288.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	-484.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-386.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-326.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	5.2% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	14.3% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	13.5% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-107.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-16.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-79.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.67x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.21x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.01x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.05x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.03x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	43.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	42.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	38.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	57.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	80.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	144.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	414.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	64.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	58.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	21.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	283.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-787.3% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	-225.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1327.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-974.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-612.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-672.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-410.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-141.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-736.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-853.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-463.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-364.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-74.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	30.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+104%)	42.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+181%)	38.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+156%)	53.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+256%)	74.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+399%)	85.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+471%)	—	115.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+669%)	—	72.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+384%)	142.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+848%)	—	—	-31.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-308%)	-11.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	89.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+497%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Debt to Equity (x)	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	-0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-103%)	—	—	—	—	—	-0.57x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-181%)	—	5.05x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+622%)	—	—	—	—
Interest Coverage (x)	-21.58x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-31.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-283.68x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-3.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.36x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-0.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.57x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.65x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	—	—	—	$0.00	$131.44K	$-592.05K	$-2.65M	—	—	—	$1.64M	$-53.12K	$1.02M	$-6.00K	$-1.66K	$-7.13K	$-27.92K
Debt / EBITDA (x)	—	—	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	-0.36x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$0.01	$0.01	$0.02	$0.00	—
Free Cash Flow per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	$-0.01	$-0.00	$-0.00	—
Book Value per Share (USD)	$-0.46	$-0.91	$-1.13	$-1.06	$-1.04	$-0.75	$-0.20	$-2.20	$-1.59	$-0.04	$-0.02	$0.00	$0.00	$0.03	$0.03	$-0.00	—
Tangible Book Value per Share (USD)	$-0.48	$-0.91	$-1.13	$-1.06	$-1.04	$-0.78	$-0.20	$-2.20	$-1.59	$-0.04	$-0.02	$0.00	$0.00	$0.03	$0.03	$-0.00	—
Basic Weighted Avg Shares (shares)	—	—	—	—	—	—	—	—	—	—	—	—	117.38M	106.15M	50.56M	37.00M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Working Capital (USD)	$-7.49M	$-8.09M	$-6.24M	$-5.05M	$-4.16M	$-2.08M	$495.68K	$-5.81M	$-1.58M	$-2.35M	$-3.44M	$-1.72M	$-833.19K	$-876.75K	$3.49M	$-83.64K	—
LT Debt (USD)	—	—	—	$0.00	$99.86K	—	—	—	—	—	$1.86M	—	$1.13M	—	—	—	—
Total Equity (USD)	$-11.22M	$-12.12M	$-9.82M	$-8.20M	$-6.96M	$-4.09M	$-1.06M	$-5.71M	$-3.89M	$-8.13M	$-3.28M	$306.30K	$222.79K	$2.84M	$3.49M	$-172.71K	$-18.12K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$797.24K	$7.67K	$89.16K	$213.84K	$48.27K	$122.62K	$240.26K	$376.66K	$657.27K	$701.77K	$924.73K	$1.17M	$714.96K	$868.16K	$771.76K	$144.40K	—
Depreciation Expense (USD)	$44.00K	$33.15K	$25.63K	$27.45K	$64.33K	$28.92K	$15.96K	$5.39K	$6.12K	$4.33K	$2.29K	$3.14K	$3.16K	$1.99K	—	—	—
Net Income, GAAP (USD)	$-3.44M	$-5.11M	$-3.77M	$-4.38M	$-5.21M	$-3.51M	$-6.05M	$-6.58M	$-29.71M	$-5.90M	$-4.67M	$-3.13M	$-3.84M	$-885.81K	$-408.97K	$-154.59K	—
Operating Cash Flow (USD)	$-2.30M	$-1.10M	$-1.85M	$-2.04M	$-3.54M	$-2.15M	$-2.94M	$-1.83M	$-2.54M	$-1.99M	$47.86K	$167.67K	$103.46K	$-927.76K	$-128.39K	$-114.34K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 69 quarters

BioCorRx Inc.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BICX with peers